Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.

It's the latest stride by Nvidia and the pharmaceutical industry to harness AI to try to reduce costs and shorten the time it takes to bring cures to patients.

Eli Lilly and NVIDIA will build a new supercomputer to accelerate drug discovery and shorten development cycles.